SCHEMBL26433362

SCHEMBL26433362

c1cncc(-c2cc3c(cn2)c2cnc(-c4cccnc4)c4c5cc6c7c(-c8cccnc8)ncc8c9cnc(-c%10cccnc%10)cc9n(c6cc5n3c24)c87)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 13/20 0.46
CYP2A6 P11509 4/20 0.42
PIM2 Q9P1W9 5/20 0.41
PIM3 Q86V86 4/20 0.41
CYP2C19 P33261 3/20 0.41
CYP2E1 P05181 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2B6 P20813 2/20 0.41
CYP3A4 P08684 3/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26433334 0.85 IDO1 (0.38) PIM1PIM2PIM3ADORA1
SCHEMBL26433357 0.76 TDO2 (0.41)
SCHEMBL26433360 0.75 PIM1 (0.43) PIM1PIM2PIM3CYP1A2ALOX15
SCHEMBL20133108 0.69 CYP2A6 (0.48) PIM1CYP2A6PIM2PIM3CYP2C19
SCHEMBL26433351 0.68 CYP19A1 (0.42) PIM1CYP2A6PIM2PIM3CYP2C19
SCHEMBL22049805 0.66 PIM1 (0.56) PIM1CYP2A6PIM2PIM3CYP3A4
SCHEMBL26433297 0.64 CYP11B1 (0.37) CYP2A6CYP2C19CYP2E1CYP2C9CYP2B6
SCHEMBL14689417 0.64 PIM1 (1.00) PIM1PIM2PIM3
SCHEMBL26433381 0.62 GSK3A (0.39) PIM1PIM2PIM3
SCHEMBL18876259 0.60 CYP2A6 (0.64) PIM1CYP2A6PIM2PIM3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, CRY1 PIM1 1525/4885CYP2A6 223/4885PIM2 2269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.